Bantam Pharmaceutical is a drug discovery and development company leveraging the power of mitochondrial dynamics to address critical unmet needs in oncology. Using its unique expertise in mitochondrial cellular biology, Bantam is advancing novel, first-in-class oral small molecule therapeutics for difficult-to-treat hematological and solid tumors. The company currently holds an active Investigational New Drug (IND) application in the U.S. and a Clinical Trial Application (CTA) in Canada for its lead candidate, BTM-3566, targeting B-cell malignancies, with plans to expand clinical development into solid tumors.
About BTM-3566
BTM-3566 is a novel, orally available small molecule designed to target a wide range of cancers, including both hematologic and solid tumors. Its initial clinical focus is on mature B-cell lymphomas, such as mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), and follicular lymphoma (FL). In preclinical studies, BTM-3566 demonstrated potent anti-cancer activity, driving significant tumor regression – and in many cases, complete tumor elimination – in models resistant to standard treatments, including CAR-T cell therapy. BTM-3566 works by disrupting the mitochondrial function in tumor cells, triggering their natural cell death process (apoptosis). With its unique mechanism of action and strong preclinical data, Bantam also plans to expand clinical development into solid tumors, broadening its potential impact for patients with limited treatment options.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 8 Davis Dr, Durham,north Carolina 27709,united States
- Phone
- 646) 598-4823
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- bantampharma.com
- Keywords
- Oncology, refractory DLBCL, Gastroesophageal cancer, Tumor cell mitochondria, ATF-4 Integrated Stress Response, B-cell Lymphoma, Uterine cancer, Cholangiocarcinoma, Acute Myeloid Leukemia, refractory MCL, Cancer Drug Development.
- HQ
- Durham, North Carolina
Bantam Pharmaceutical Questions
Bantam Pharmaceutical's helpline number is 646) 598-4823
Bantam Pharmaceutical's website is bantampharma.com
Bantam Pharmaceutical's LinkedIn profile is https://www.linkedin.com/company/bantam-pharmaceutical-llc
Bantam Pharmaceutical has
7 employees.
View email and phone details for 7
employees at Bantam Pharmaceutical.
Bantam Pharmaceutical's industry is
Pharmaceutical Manufacturing
Bantam Pharmaceutical's top competitors are
Leap Therapeutics,
Ankyra Therapeutics,
Bicara Therapeutics,
Obsidian Therapeutics,
Madera Therapeutics,
Harbinger Health,
Impact Pharmaceutical Services,
Auron Therapeutics, Inc.,
Repare Therapeutics,
Sunrise Pharmaceutical, Inc.
Bantam Pharmaceutical's support email address is info@bantampharma.com
Bantam Pharmaceutical's categories are Pharmaceutical Manufacturing
Bantam Pharmaceutical's founding year is 2015
